Menu

Objectifs d’apprentissage

À la fin de la réunion annuelle 2026 de la SCR, les participants seront en mesure:

1

Passer en revue les avancées actuelles dans la prise en charge médicale des maladies rétiniennes, y compris les nouvelles thérapies pharmacologiques et les stratégies thérapeutiques en constante évolution pour la dégénérescence maculaire liée à l'âge, l'œdème maculaire diabétique et l'occlusion veineuse rétinienne.

2

Interpréter l'imagerie rétinienne avancée et les biomarqueurs cliniques afin d'améliorer la précision du diagnostic, la surveillance de la maladie et la prise de décision thérapeutique.

3

Discuter des techniques chirurgicales contemporaines et de la prise de décision clinique en chirurgie vitréo-rétinienne, y compris les stratégies de prise en charge du décollement de la rétine, des trous maculaires et des affections vitréo-rétiniennes complexes.

4

Évaluer les technologies émergentes et les innovations, notamment l'intelligence artificielle, la thérapie génique et les nouvelles plateformes thérapeutiques susceptibles d'influencer la pratique clinique future en matière de rétine.

Accréditation

La présente activité est une activité d’apprentissage collectif agréée (section 1), au sens que lui donne le programme de Maintien du certificat du Collège royal des médecins et chirurgiens du Canada; elle a été approuvée par La Société canadienne d’ophtalmologie (SCO). Vous pouvez déclarer un maximum de 9 heures (les crédits sont calculés automatiquement). Les opinions et le contenu spécifiques de cet événement ne sont pas nécessairement ceux de SCO et relèvent de la seule responsabilité de l'organisateur ou des organisateurs.

Ordre Du Jour

Friday, April 17, 2026

PLENARY SESSION #1 – SURGERY I
Cinema – first floor
Co-chairs: Bernard Hurley, MD & Keyvan Koushan, MD

3:30 PMWelcome and Opening Remarks
Co-chairs: Bernard Hurley, MD; Keyvan Koushan, MD
3:40 – 4:35 PMSurgical Video Session: East vs West
Moderators: Amin Kherani, MD and David Wong, MD
4:40 – 4:50 PMCongenital Vitreoretinal Disorders
Audina Berrocal, MD
4:52 – 5:02 PMPower of Vitrectomy Cutter Biopsy
Hung-Da Chou, MD
5:02 – 5:12 PMMyopic Traction Maculopathy Surgery: A Beginner's Guide
Hung-Da Chou, MD
5:12 – 5:30 PMQ&A
6:00 PMWelcome Reception – New Fort Hall

Saturday, April 18, 2026

7:00 AMBreakfast – Princes' Gate Pre-function Area / Princes' Gate Ballroom

PLENARY SESSION #2 – ANTI-VEGF
Cinema – first floor
Moderators: TBD

8:30 – 8:35 AMWelcome and Review of Agenda
Bernard Hurley, MD; Keyvan Koushan, MD
8:35 – 8:45 AMBiomarkers in Diabetic Macular Edema
Adrian Koh Hock Chuan, MD, MBBS
8:47 – 8:55 AMSPECTRUM: First Canadian Real‑world Outcomes with Aflibercept 8 mg in Previously Treated Diabetic Macular Edema
Keyvan Koushan, MD
8:57 – 9:05 AMLong-term Canadian Real-world Experience With Faricimab in Patients with Neovascular Age-related Macular Degeneration and Diabetic Macular Edema
Parth Shah, MD
9:07 – 9:17 AMBattle of the Next Generation Therapies
John Kitchens, MD
9:19 – 9:27 AMAflibercept 8 mg in Retinal Vein Occlusion: Final Results from the QUASAR Study
Varun Chaudhary, MD
9:29 – 9:37 AMSPECTRUM: First Canadian Real‑world Outcomes With Aflibercept 8 mg in Previously Treated Neovascular Age-related Macular Degeneration
Raman Tuli, MD
9:39 – 9:49 AMCurrent Management of Polypoidal Choroidal Vasculopathy in 2026
Adrian Koh Hock Chuan, MD, MBBS
9:51 – 10:05 AMQ&A
10:15 ‒ 11:00 AMFor more details, click here
11:00 ‒ 11:25 AMBreak – Poster Session – Princes' Gate Pre-function Area
POSTER SESSION – Library Collection Lounge

PLENARY SESSION #3 – SURGERY II
Cinema – first floor
Moderators: TBD

11:30 – 11:40 AMLamellar Macular Holes - What's Going On and What Should We Do?
David Steel, MBBS, MD(Res)
11:42 – 11:50 AMIs 20/20 Vision Good Enough? Outcomes of Complete Pars Plana Vitrectomy During IOL Exchange for Lens Opacification in Patients with Preserved Visual Acuity
Robert Gizicki, MD
11:52 AM – 12:00 PMSuprachoroidal Viscopexy for Rhegmatogenous Retinal Detachment: Two-year Safety and Efficacy Outcomes
Aurora Pecaku, MD
12:00 – 12:10 PMQ&A
12:12 – 12:20 PMPneumatic Retinopexy as a Temporizing Treatment Strategy for Retinal Detachment: A Population-based Cohort Study
Gareth Mercer, MD, PhD
12:22 – 12:30 PMVitrectomy After Successful Pneumatic Retinopexy for Rhegmatogenous Retinal Detachment
Robert Gizicki, MD
12:32 – 12:42 PMTamponade Choice with Vitrectomy for Rhegmatogenous Retinal Detachment; Does It Make a Difference?
David Steel, MBBS, MD(Res)
12:40 – 12:50 PMQ&A
12:50 – 1:35 PMLUNCH – Princes' Gate Pre-function Area / Princes' Gate Ballroom
POSTER SESSION – Library Collection Lounge
1:35 ‒ 2:15 PMFor more details, click here

PLENARY SESSION #4 – POTPOURRI
Cinema – first floor
Moderators: TBD

2:25 – 2:35 PMWhat in the World is Going on in the United States?
John Kitchens, MD
2:37 – 2:45 PMIn Vivo Assessment of Peripheral Vitreous Traction with Ultra-widefield Swept-source OCT in Rhegmatogenous Retinal Detachment
Isabela Martins Melo, MD
2:47 – 2:57 PMPediatric Retina Detachment
Audina Berrocal, MD
2:57 – 3:07 PMQ&A
3:09 – 3:19 PMRetinopathy of Prematurity in 2026
Audina Berrocal, MD
3:21 – 3:29 PMComparative Outcomes of Secondary Intraocular Lens Fixation Techniques
Kirill Zaslavsky, MD
3:31 – 3:39 PMComparison of Clinical Outcomes of Sutureless Flanged Intrascleral (Yamane) and Four-point Gore-Tex Suture Techniques for Intraocular Lens Fixation
Robert Gizicki, MD
3:39 – 3:45 PMQ&A
3:50 ‒ 4:35 PMFor more details, click here
4:35 – 5:00 PMBREAK – Princes' Gate Pre-function Area / Princes' Gate Ballroom
POSTER SESSION – Library Collection Lounge
5:00 – 5:45 PMCRS Annual General Meeting
6:30 PMRECEPTION – Princes' Gate Pre-function Area
GALA – Princes' Gate Ballroom

Sunday, April 19, 2026

7:00 AMBreakfast – Princes' Gate Pre-function Area / Princes' Gate Ballroom

PLENARY SESSION #5 – AGE-RELATED MACULAR DEGENERATION
Cinema – first floor
Moderators: TBD

8:35 – 8:45 AMHow to Assess Functional Loss and Progression in Geographic Atrophy
Ursula Schmidt-Erfurth, MD
8:47 – 8:55 AMOne Year Results of a Phase 2 Pharmacodynamic Study: Subretinal Delivery of Investigational Gene Therapy Sura-vec (ABBV-RGX-314) for Neovascular Age-related Macular Degeneration
Robert Gizicki, MD
8:57 – 9:05 AMReduction in Subretinal Hyperreflective Material Volume with Faricimab vs Aflibercept 2 mg in Treatment-naïve Neovascular Age-related Macular Degeneration: A TENAYA/LUCERNE Post Hoc Analysis
Nirojini Sivachandran, MD, PhD
9:05 – 9:10 AMQ&A
9:10 – 9:20 AMHow do You Diagnose Polypoidal Choroidal Vasculopathy Without Indocyanine Green Angiography?
Adrian Koh Hock Chuan, MD, MBBS
9:22 – 9:30 AMAvacincaptad Pegol for Geographic Atrophy: 3.5-Year Results from the GATHER2 Open-label Extension Trial
Varun Chaudhary, MD
9:32 – 9:42 AMAge-related Macular Degeneration as a Complex Disease Between Atrophy and Neovascularization
Ursula Schmidt-Erfurth, MD
9:42 – 10:00 AMQ&A
10:00 – 10:30 AMBREAK – Princes' Gate Pre-function Area / Princes' Gate Ballroom
POSTER SESSION – Library Collection Lounge

PLENARY SESSION #6 – Artificial Intelligence
Cinema – first floor
Moderators: TBD

10:32 – 10:42 AMPractical Ways to Use Existing AI in Clinic
David Steel, MBBS, MD(Res)
10:44 – 10:52 AMBaseline Peripheral Vascular Leakage is Linked to Treatment Response in Patients With Central Retinal Vein Occlusion: A Pilot Study
Alan Cruess, MD
10:54 – 11:04 AMAI as a Management Tool for Neovascular Age-related Macular Degeneration
Ursula Schmidt-Erfurth, MD
11:04 – 11:20 AMQ&A

PLENARY SESSION #7 – Surgery III
Cinema – first floor
Moderators: TBD

11:25 – 11:35 AMHow Should We Treat Refractory Macular Holes?
David Steel, MBBS, MD(Res)
11:37 – 11:44 AMPredictors of Primary Anatomic Reattachment With Pneumatic Retinopexy for Rhegmatogenous Retinal Detachment
Aurora Pecaku, MD
11:46 – 11:54 AMOuter Retinal Corrugations Indicate Retinal Break Status in Rhegmatogenous Retinal Detachment
Jeffrey Mah, MD
11:56 AM – 12:06 PMDouble the Adjuncts, Double the Confidence in Macular Surgery
Hung-Da Chou, MD
12:06 – 12:20 PMQ&A
12:20 PMConcluding Remarks
Bernard Hurley, MD, and Keyvan Koushan, MD
12:30 PMGRAB & GO LUNCH (LOCATED OUTSIDE CINEMA)
Please check back soon.

Présentateurs d'affiches

Isabela M. Melo, M.D. – Toronto, ON

  • Posterior Hyaloid Discontinuity on Optical Coherence Tomography in Partial Posterior Vitreous Detachment and Vitreomacular Traction
  • Impact of Baseline Morphological Stage on Post-operative Outcomes in Rhegmatogenous Retinal Detachment

Parnian Arjmand, M.D. – Toronto, ON

  • Juxtafoveal Retinal Arterial Macroaneurysm: The Role of Ancillary Imaging

Amin Kherani, M.D. – Calgary, AB

  • Intraocular foreign body injuries from a Calgary perspective – a retrospective case series

Carl Shen, M.D. – Hamilton, ON

  • Intraretinal silicone oil migration: An under recognized OCT phenotype

Paola Oquendo, M.D. – Hamilton, ON

  • Comparison of the Photoreceptor Mosaic Before and After Macular Hole Surgery with High Resolution Adaptive Optics Imaging
  • Epiretinal Membrane and Associated Tractional Abnormalities Following Rhegmatogenous Retinal Detachment Repair

Hatim Batawi, M.D. – Toronto, ON

  • Outer Retinal Hyperreflective Dots, A Potential Biomarker in Rhegmatogenous Retinal Detachment

Khaldon Abbas – Vancouver, BC

  • Characteristics of No-show appointments at a multicenter retina subspeciality practice

Aurora Pecaku, M.D. – Toronto, ON

  • Reattachment Rate with Pneumatic Retinopexy vs Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment with a Single Break in Detached Retina Only

Irina Sverdlichenko – Toronto, ON

  • Macular Hole Associated Retinal Detachment in High Myopic Patients: Case series and Overview of a Novel Surgical Technique

Aaditeya Jhaveri – Toronto, ON

  • Optical coherence tomography biomarkers as potential predictors for visual function and response to intravitreal therapy in diabetic macular edema: a review

Fowad Daud – Hamilton, ON

  • Combined versus Sequential Pars Plana Vitrectomy and Phacoemulsification for Macular Hole and Epiretinal Membrane – A Systematic Review and Meta-Analysis

Milena Cioana – Toronto, ON

  • Post-procedural endophthalmitis visual outcomes by microorganism: A systematic review and meta-analysis
32 Burdock Boulevard, Brantford, ON, N3R 6N2, Canada
admin@crsscr.ca
Copyright © Canadian Retina Society. All Rights Reserved
envelopemap-markercrossmenu